Insider Shareholders with Direct Ownership of Tela Bio, Inc. (TELA)
This section provides a comprehensive overview of the insiders with direct ownership of Tela Bio, Inc. (TELA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
TELA Bio, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Orbimed Advisors Llc
> 10% Shareholder |
1,843,530 | 0 | 3,027,542 $8.66 Million | 2 |
Nov 13, 2019
Added 24.41%
|
|
Antony Koblish
Chief Executive Officer |
325,427 | 20,615 | 458,897 $1.31 Million | 14 |
Oct 24, 2024
Added 16.23%
|
|
Roberto Cuca
COO and CFO |
156,236 | 4,085 | 155,388 $444,409 | 12 |
Oct 24, 2024
Added 29.32%
|
|
Paul Talmo
Chief Technology Officer |
67,922 | 7,310 | 91,082 $260,494 | 12 |
Oct 24, 2024
Added 19.61%
|
|
Maarten Persenaire
Chief Medical Officer |
12,000 | 0 | 90,887 $259,936 | 1 |
Feb 24, 2021
Added 11.66%
|
|
Gregory A. Firestone
Chief Commercial Officer |
42,216 | 2,056 | 57,279 $163,817 | 9 |
Oct 24, 2024
Added 10.42%
|
|
Peter C. Murphy
Chief Commercial Officer |
54,298 | 6,529 | 48,129 $137,648 | 13 |
Mar 31, 2024
Reduced 0.34%
|
|
Megan Smeykal
Chief Accounting Officer |
23,800 | 3,539 | 29,000 $82,940 | 12 |
Mar 31, 2024
Reduced 0.33%
|
|
Ellis Skott Greenhalgh
Chief Technology Officer |
18,289 | 973 | 27,826 $79,582 | 4 |
Feb 24, 2022
Reduced 3.38%
|
|
Nora Brennan
Chief Financial Officer |
14,028 | 0 | 17,696 $50,610 | 2 |
Mar 31, 2021
Added 14.2%
|
|
Vincent J Burgess
Director |
15,380 | 0 | 15,380 $43,986 | 4 |
Jun 04, 2024
Added 21.65%
|
|
Lisa N Colleran
Director |
10,520 | 0 | 10,520 $30,087 | 3 |
Jun 04, 2024
Added 28.77%
|
|
Federica F. O'Brien
Director |
10,520 | 0 | 10,520 $30,087 | 3 |
Jun 04, 2024
Added 28.77%
|
|
Kurt Azarbarzin
Director |
10,520 | 0 | 10,520 $30,087 | 3 |
Jun 04, 2024
Added 28.77%
|
|
Douglas G Evans
Director |
10,520 | 0 | 10,520 $30,087 | 3 |
Jun 04, 2024
Added 28.77%
|
|
Jeffrey Blizard
Director |
6,375 | 0 | 6,375 $18,232 | 1 |
Jun 04, 2024
Added 50.0%
|
|
John Nosenzo
Director |
6,270 | 0 | 6,270 $17,932 | 2 |
Jun 01, 2023
Added 33.33%
|
|
Quaker Bio Ventures Ii Lp
> 10% Shareholder |
0 | 1,751,100 | 0 $0 | 1 |
Jun 02, 2022
Reduced 100.0%
|